Answer
Women of childbearing potential should use contraception during tafamidis meglumine treatment and for one month after stopping treatment because of its prolonged half-life.
Sources for this answer
- Vyndaqel 20 mg soft capsulesPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 18Document updated
Sources checked